Stem Cells Targeting Inflammation as Potential Anti-aging Strategies and Therapies

  title={Stem Cells Targeting Inflammation as Potential Anti-aging Strategies and Therapies},
  author={Rafael Gonzalez and Dave Woynarowski and Luis Geffner},
Human aging is associated with a vast array of clinical disorders that all relate to the body’s inability to maintain homeostasis. In our bodies, the healing process requires tight control of the acute inflammatory response. When the levels of inflammatory markers such as interleukin-6, tumor necrosis factor alpha, and C-reactive protein are elevated, there is a direct correlation with several chronic diseases of aging such as cardiovascular disease, cognitive decline, and physical disability… 

Figures and Tables from this paper

Mesenchymal Stem Cell Therapy for Aging Frailty

It is proposed that frailty can be treated and the link between frailty and chronic inflammation offers a potential therapeutic target, addressable by cell therapy.

Frailty and Rejuvenation with Stem Cells: Therapeutic Opportunities and Clinical Challenges

It is concluded that intravenous infusion of allogenic MSCs is safe, well tolerated, and preliminarily effective clinically and more preclinical experiments and clinical trials are warranted to precisely elucidate the mechanism, safety, and efficacy of frailty stem cell therapy.

Neuroimmunomodulatory properties of DPSCs in an in vitro model of Parkinson's disease

DPSCs were shown to have immunomodulatory capacities which could probably serve as secondary effects upon transplantation in a CRT regime, thereby indicating their applicability for CRT especially in PD conditions.

Regeneration of Salivary Gland Defects of Diabetic Wistar Rats Post Human Dental Pulp Stem Cells Intraglandular Transplantation on Acinar Cell Vacuolization and Interleukin-10 Serum Level

Transplantation of HDPSC was able to regenerate submandibular salivary gland defects in diabetic rats by decreasing acinar cell vacuolization and slightly increase IL-10 serum level.



Anti-Inflammatory Effects of Adult Stem Cells in Sustained Lung Injury: A Comparative Study

AM-MSC may be more effective in reducing injury following delayed injection in the setting of repeated lung injury as shown in mice treated with a repeat dose bleomycin-induced model of lung injury.

Innate immunity and inflammation in ageing: a key for understanding age-related diseases

Low responder genotypes involved in regulation of innate defence mechanisms, might better control inflammatory responses and age-related disease development, resulting in an increased chance of long life survival in a "permissive" environment with reduced pathogen load, medical care and increased quality of life.

Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

  • C. FranceschiJ. Campisi
  • Medicine, Biology
    The journals of gerontology. Series A, Biological sciences and medical sciences
  • 2014
The session on inflammation of the Advances in Gerosciences meeting held at the National Institutes of Health/National Institute on Aging in Bethesda on October 30 and 31, 2013 was aimed at defining these important unanswered questions about inflammaging.

Bone Marrow Stem Cell Derived Paracrine Factors for Regenerative Medicine: Current Perspectives and Therapeutic Potential

The current review reflects the rapid shift of interest from BMSC to B MSC-CM to alleviate many logistical and technical issues regarding cell therapy and evaluates its future potential as an effective regenerative therapy.

Molecular Inflammation as an Underlying Mechanism of the Aging Process and Age-related Diseases

The molecular basis of low-grade, unresolved, subclinical inflammation as a major risk factor for exacerbating the aging process and age-related diseases is explored and redox-sensitive transcription factors, NF-κB and FOXO, play essential roles in the expression of pro-inflammatory mediators and anti-oxidant enzymes.

Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine

Allogeneic MSC treatments, categorized as a drug by regulatory agencies, have been widely pursued, but new studies demonstrate the efficacy of autologous MSC therapies, even for individuals affected by a disease state.

Mesenchymal stem cell treatment for autoimmune diseases: a critical review.

Future advances from stem cell science can be expected to pinpoint significant MSC subpopulations and/or stem cell markers for improved regenerative or immunoregulatory properties.